Following were the major Smallcap losers in the biotech sector on Friday. Keep these stocks on your radar this week.
Provention Bio, Inc (NASDAQ:PRVB) was one of the notable losers in Friday’s trading session with a fall of 28.75% to close at $7.61. The stock saw total volume of over 10.42 million shares exchanged hands, well above its average volume of 2.46 million shares. The company came under pressure after the company receives a favorable vote for Teplizumab from FDA Advisory Committee. The stock has slumped 40% in the past quaretr. The stock is trading 62% below its 52-week high and 24% higher from its 52-week low.
CytomX Therapeutics (NASDAQ:CTMX) was under pressure on Friday as the stock decreased 12.58% to $7.16. After opening at $7.69, the stock has moved within a wide range of $7.15 – 7.85. The stock has gained 9% so far in 2021, but down 15% over the past quarter. Last week, the company announced that Amy Peterson, M.D., chief development officer, will participate in a virtual fireside chat at the Jefferies Virtual Healthcare Conference on June 3rd at 2:00 p.m. ET.
Humanigen, Inc (NASDAQ:HGEN) continues to be in downtrend as the stock has seen a major pullback after the recent strong rally. . The stock was down 11% at $20.23 on Friday. The stock has soared almost 172% over the past six months. Last week, the company announced that the company submitted an application to the US Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) for lenzilumab for the treatment of patients hospitalized with COVID-19.
